Alyeska Investment Group buys $83,746,949 stake in Hill-Rom Holdings (HRC)

Hill-Rom Holdings (HRC) : Alyeska Investment Group scooped up 445,039 additional shares in Hill-Rom Holdings during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 1,443,664 shares of Hill-Rom Holdings which is valued at $83,746,949.Hill-Rom Holdings makes up approximately 0.82% of Alyeska Investment Group’s portfolio.

Other Hedge Funds, Including , Riverhead Capital Management sold out all of its stake in HRC during the most recent quarter. The investment firm sold 11,176 shares of HRC which is valued $648,320.Globeflex Capital L P boosted its stake in HRC in the latest quarter, The investment management firm added 155 additional shares and now holds a total of 44,493 shares of Hill-Rom Holdings which is valued at $2,581,039. Hill-Rom Holdings makes up approx 0.66% of Globeflex Capital L P’s portfolio.Matarin Capital Management reduced its stake in HRC by selling 815 shares or 0.71% in the most recent quarter. The Hedge Fund company now holds 114,381 shares of HRC which is valued at $6,635,242. Hill-Rom Holdings makes up approx 0.85% of Matarin Capital Management’s portfolio.Mutual Of America Capital Management boosted its stake in HRC in the latest quarter, The investment management firm added 9,676 additional shares and now holds a total of 48,546 shares of Hill-Rom Holdings which is valued at $2,635,077. Hill-Rom Holdings makes up approx 0.05% of Mutual Of America Capital Management’s portfolio.

Hill-Rom Holdings closed down -0.06 points or -0.10% at $59.25 with 3,16,553 shares getting traded on Thursday. Post opening the session at $59.37, the shares hit an intraday low of $58.65 and an intraday high of $59.39 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Hill-Rom Holdings reported $0.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.76. The company had revenue of $655.40 million for the quarter, compared to analysts expectations of $646.61 million. The company’s revenue was up 38.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

Investors should note that on Jul 20, 2016, Hill-Rom Holdings announced a cash dividend of $0.1700. The company’s management has announced Sep 14, 2016 as the ex-dividend date and fixed the record date on Sep 16, 2016. The payable date has been fixed on Sep 30, 2016.

Many Wall Street Analysts have commented on Hill-Rom Holdings. Hill-Rom Holdings was Upgraded by Morgan Stanley to ” Overweight” on Jun 16, 2016.

Hill-Rom Holdings Inc. (Hill-Rom) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility Wound Care and Prevention Clinical Workflow Surgical Safety and Efficiency and Respiratory Health. The Company operates in three segments: North America Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services as well as its clinical workflow solutions in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

Leave a Reply

Hill-Rom Holdings - Is it time to Sell?

Top Brokerage Firms are advising their investors on Hill-Rom Holdings. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.